The 2x Long VIX Futures ETF seeks daily investment results, before fees and expenses, that correspond to twice (200%) the performance of the Long VIX Futures Index (LONGVOL). Maintained by Cboe, LONGVOL expresses the daily performance of a theoretical portfolio of first- and second-month VIX futures contracts that are rolled daily, with its settlement value derived from a 15-minute time-weighted average price (TWAP) during the regular equity session. UVIX, launched by Volatility Shares in March 2022, is a passive, daily-resetting leveraged product that takes a long position in short-term volatility.
Unlike equity ETFs, UVIX does not hold a diversified basket of stocks and has no sector allocation. Its exposure consists of front-month VIX futures contracts, cash, and money-market instruments. The VIX (Cboe Volatility Index) measures the market's 30-day expectation of S&P 500 volatility implied by options pricing. UVIX carries a management fee of 1.65%, and because its leverage resets daily, its returns can diverge significantly from a simple 2x multiple of the VIX over any period longer than a single day.
Over the last 30 days, UVIX rose approximately 13%, moving from a closing level near $35.79 to about $40.56. The move was not a smooth trend: the fund spent most of the period grinding near its lows before spiking sharply in mid-October, when daily volume surged and intraday prices jumped from the low $30s toward the low $40s. This pattern is characteristic of long-volatility exposure, which tends to move abruptly rather than gradually.
The quarterly picture is the mirror image. Over the last three months, UVIX fell roughly 35%, declining from about $62.05 to $40.56. In other words, the recent 30-day rebound only partially retraced a longer, deeper drawdown. The contrast between the two timeframes illustrates the fund's core dynamic: steady decay in low-volatility regimes punctuated by sharp, short-lived rallies when fear re-enters the market.
The 30-day advance was driven almost entirely by a repricing of volatility expectations rather than any change in underlying corporate fundamentals. In mid-October, implied volatility across equity markets climbed, lifting VIX futures and, in turn, the LONGVOL index that UVIX tracks. Because UVIX targets 2x daily exposure, a rise in its benchmark translated into a disproportionately large move in the fund's share price, with elevated trading volume confirming active repositioning.
The VIX futures curve's normal condition is contango (an upward-sloping curve), which forces funds rolling expiring contracts to buy higher-priced longer-dated futures and steadily erodes value. During the mid-October volatility event, a shift in the term structure temporarily reversed that drag, allowing UVIX to capture leveraged gains. The absence of equity-sector leadership or individual holdings means the entire move can be attributed to shifts in the level and shape of the VIX futures curve and to investor hedging demand.
The roughly 35% quarterly decline reflects the cumulative effect of contango and volatility drag. When the VIX futures curve remains in contango and realized volatility stays low, a daily-resetting leveraged fund loses value through the routine roll of futures contracts and through the compounding effect of rebalancing in a trending-down market. This structural erosion occurs even when the broader equity market is modestly positive or range-bound.
The quarterly trend also highlights the asymmetry of the product: the fund's gains are concentrated in brief episodes of market stress, while its losses accumulate steadily the rest of the time. Institutional and tactical traders use vehicles such as UVIX primarily as short-term hedges or speculative tools, and the fund's counterpart, the -1x Short VIX Futures ETF (SVIX), expresses the inverse view. The wide quarterly drawdown followed by a sharp 30-day bounce is consistent with this hedging-oriented usage pattern rather than with long-horizon asset accumulation.
Tickeron's AI Screener is an AI-powered stock and ETF discovery platform that helps investors scan thousands of securities using technical indicators, fundamentals, volatility metrics, price patterns, industry filters, AI-generated signals, and performance characteristics. By combining quantitative criteria with machine-driven analysis, the tool is designed to surface candidates that manual screening might overlook, from momentum breakouts to volatility-driven setups. For investors monitoring fast-moving products such as leveraged volatility ETFs, screening on volatility measures and price patterns can add a layer of discipline to idea generation. Explore the AI Screener to evaluate how systematic, data-driven filters might sharpen your own market research workflow.
Going forward, the principal variable for UVIX is the level and shape of the VIX futures curve. Sustained low realized volatility and a steep contango term structure would likely continue to pressure the fund, while any resurgence in equity-market stress, hedging demand, or risk-aversion could trigger sharp, leveraged rallies. Investors should monitor implied volatility levels, the slope of the futures curve, and the pace of institutional hedging activity.
Macroeconomic conditions also matter indirectly. Interest-rate expectations, inflation trends, and economic growth data shape equity risk appetite and, by extension, demand for volatility protection. A broadening of sector rotation or an earnings-driven repricing could lift realized volatility and support the fund, whereas a period of calm, orderly markets would reinforce the structural decay embedded in a daily-resetting 2x long-volatility strategy. Because the product is engineered for short holding periods, its risks include contango erosion, volatility drag, and leveraged compounding, all of which are most relevant to investors who hold the fund across multiple sessions rather than using it tactically.
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.
Moving lower for three straight days is viewed as a bearish sign. Keep an eye on this stock for future declines. Considering data from situations where UVIX declined for three days, in 374 of 381 cases, the price declined further within the following month. The odds of a continued downward trend are 90%.
UVIX broke above its upper Bollinger Band on October 22, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.
The Aroon Indicator for UVIX entered a downward trend on October 15, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
The Stochastic Oscillator suggests the stock price trend may be in a reversal from a downward trend to an upward trend. 57 of 59 cases where UVIX's Stochastic Oscillator exited the oversold zone resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 90%.
The Momentum Indicator moved above the 0 level on October 16, 2026. You may want to consider a long position or call options on UVIX as a result. In 76 of 85 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 89%.
UVIX moved above its 50-day moving average on October 30, 2026 date and that indicates a change from a downward trend to an upward trend.
The 10-day moving average for UVIX crossed bullishly above the 50-day moving average on October 30, 2026. This indicates that the trend has shifted higher and could be considered a buy signal. In 11 of 11 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are 90%.
Following a +15.16% 3-day Advance, the price is estimated to grow further. Considering data from situations where UVIX advanced for three days, in 139 of 160 cases, the price rose further within the following month. The odds of a continued upward trend are 87%.
Category Trading